

(Sharecast News) - Drug development services provider hVIVO achieved its "strongest potential sales pipeline" for several years, executive chairman Tr...


LONDON (Alliance News) - hVIVO PLC said Thursday that increased revenue generation and ongoing costs savings led to a narrowed loss for the first half...


Friday 14 September JD WetherspoonHalf Year ResultsTriple Point Social HousingHalf Year


LONDON (Alliance News) - Shares in hVIVO PLC rose on Monday after the scientific research company announced positive results from the study of its flu...


LONDON (Alliance News) - Clinical development and drug discovery business hVIVO PLC said Thursday its loss narrowed in 2017 as Chief Executive Kym Den...


LONDON (Alliance News) - hVIVO PLC said on Monday it received encouraging initial results from a Phase IIb study examining FLU-v as a potential univer...